# FDA Inspection 1035060 - Reading Hospital - November 29, 2017

Source: https://www.keypedia.com/records/fda_inspections/reading-hospital/af58d1a2-3a33-4bfa-bae1-2cf3e6df8432
Source feed: FDA_Inspections

> FDA Inspection 1035060 for Reading Hospital on November 29, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1035060
- Company Name: Reading Hospital
- Inspection Date: 2017-11-29
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1277001 - 2025-07-30](https://www.keypedia.com/records/fda_inspections/reading-hospital/a9c6b9cd-3658-475b-8b58-c60221c83f55)
- [FDA Inspection 1170357 - 2022-05-11](https://www.keypedia.com/records/fda_inspections/reading-hospital/c6d101a9-44fa-45cf-99d8-4f62dc1cd98e)
- [FDA Inspection 1170357 - 2022-05-11](https://www.keypedia.com/records/fda_inspections/reading-hospital/75b948de-4c97-4b4e-9ced-cac491408245)
- [FDA Inspection 1170357 - 2022-05-11](https://www.keypedia.com/records/fda_inspections/reading-hospital/5e0700ca-c918-41f1-ab46-b3185fe9b5e6)
- [FDA Inspection 1035060 - 2017-11-29](https://www.keypedia.com/records/fda_inspections/reading-hospital/f1051e4d-f59e-4deb-898f-497428a5440d)

Company: https://www.keypedia.com/companies/reading-hospital/06325159-9820-479a-ba2e-0f47aaa24d60

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d